Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease.

Fu, Chung-Ming; Li, Lung-Chih; Lee, Yueh-Ting; Wang, Shih-Wei; Hsu, Chien-Ning

Fu, Chung-Ming; Li, Lung-Chih; Lee, Yueh-Ting; Wang, Shih-Wei; Hsu, Chien-Ning.

Afiliação

Fu CM; Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Li LC; Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Lee YT; Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Wang SW; Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Hsu CN; Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

Front Cardiovasc Med ; 8: 752468, 2021.

Article em En | MEDLINE | ID: mdl-34733897

Palavras-chave

apixaban; atrial fibrillation (AF); bleeding; chronic kidney disease; ischemic stroke; thromboembolism; warfarin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google